ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 66 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $13,000 | 0.0% | 3,300 | 0.0% | 0.00% | – |
| Q4 2017 | $13,000 | -18.8% | 3,300 | -8.3% | 0.00% | – |
| Q3 2017 | $16,000 | -86.4% | 3,600 | -72.1% | 0.00% | -100.0% |
| Q2 2017 | $118,000 | 0.0% | 12,900 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $118,000 | -33.0% | 12,900 | -43.7% | 0.00% | 0.0% |
| Q4 2016 | $176,000 | -32.6% | 22,900 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $261,000 | -26.1% | 22,900 | -20.2% | 0.00% | -50.0% |
| Q2 2016 | $353,000 | +21.7% | 28,700 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $290,000 | -55.1% | 28,700 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $646,000 | +35.7% | 28,700 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $476,000 | -26.2% | 28,700 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $645,000 | -12.7% | 28,700 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $739,000 | +18.4% | 28,700 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $624,000 | +14.9% | 28,700 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $543,000 | -18.7% | 28,700 | 0.0% | 0.01% | -16.7% |
| Q2 2014 | $668,000 | -30.8% | 28,700 | 0.0% | 0.01% | -33.3% |
| Q1 2014 | $965,000 | +13.9% | 28,700 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $847,000 | +92.9% | 28,700 | 0.0% | 0.01% | +80.0% |
| Q3 2013 | $439,000 | – | 28,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |